Market Research Logo

SurModics Inc (SRDX) - Product Pipeline Analysis, 2018 Update

Summary

SurModics Inc (SurModics) is a provider of device drug delivery coating and in vitro diagnostic technologies. The company offers wide range of advanced technologies that includes medical device coating technologies and surface modification coating technologies. Its technologies are employed in the development of new medical devices, biomedical products and in the enhancement of existing products and devices. SurModics commercializes its technologies through licensing and royalty arrangements with medical device manufacturers. SurModics sells components for in vitro diagnostic test kits and microarrays; and manufactures and distributes surface coatings to the diagnostic and biomedical research markets. The company has a wide distribution network across the world. SurModics is headquartered in Minnesota, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company SurModics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


SurModics Inc Company Overview
SurModics Inc Company Snapshot
SurModics Inc Pipeline Products and Ongoing Clinical Trials Overview
SurModics Inc – Pipeline Analysis Overview
Business Description
SurModics Inc - Key Facts
SurModics Inc - Major Products and Services
SurModics Inc Pipeline Products by Development Stage
SurModics Inc Ongoing Clinical Trials by Trial Status
SurModics Inc Pipeline Products Overview
0.018” OTW Dual Lumen PTA Catheter 0.018” OTW Dual Lumen PTA Catheter Product Overview 0.018” RX Dual Lumen PTA Catheter 0.018” RX Dual Lumen PTA Catheter Product Overview 0.035” Large Diameter OTW PTA Catheter 0.035” Large Diameter OTW PTA Catheter Product Overview 0.035” Next Generation Workhorse PTA Catheter 0.035” Next Generation Workhorse PTA Catheter Product Overview
Drug Coated Balloon - Arterio Venous (AV) Fistulas
Drug Coated Balloon - Arterio Venous (AV) Fistulas Product Overview
Drug Coated Balloon - Below The Knee (BTK)
Drug Coated Balloon - Below The Knee (BTK) Product Overview
Guide Sheath
Guide Sheath Product Overview
I-vation Sustained Drug Delivery System - TA
I-vation Sustained Drug Delivery System - TA Product Overview
Neuraxo Implant
Neuraxo Implant Product Overview
Renal Stent System
Renal Stent System Product Overview
SurVeil Drug Coated Balloon - Coronary
SurVeil Drug Coated Balloon - Coronary Product Overview
SurVeil Drug Coated Balloon - Peripheral Artery Disease
SurVeil Drug Coated Balloon - Peripheral Artery Disease Product Overview
SurVeil Drug Coated Balloon - Peripheral Artery Disease Clinical Trial
SurModics Inc - Key Competitors
SurModics Inc - Key Employees
SurModics Inc - Key Employee Biographies
SurModics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
SurModics Inc, Recent Developments
May 02, 2018: CORRECTING and REPLACING Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
May 02, 2018: Surmodics Reports Second Quarter Fiscal 2018 Results, Increases Fiscal 2018 Guidance
Apr 23, 2018: Surmodics Announces FDA Clearance of a New .018” Low-Profile PTA Balloon Dilation Catheter
Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
Jan 22, 2018: Surmodics Receives 510(K) Clearance for Telemark Coronary/Peripheral Support Microcatheter from the U.S. Food and Drug Administration
Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance
Oct 23, 2017: Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil Drug-Coated Balloon
Sep 18, 2017: Surmodics Announces Global Approvals of .014 Low-Profile PTA Balloon Dilation Catheter
Sep 13, 2017: Six-Month Data from the Surmodics SurVeil Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2017
Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
SurModics Inc Pipeline Products and Ongoing Clinical Trials Overview
SurModics Inc Pipeline Products by Equipment Type
SurModics Inc Pipeline Products by Indication
SurModics Inc Ongoing Clinical Trials by Trial Status
SurModics Inc, Key Facts
SurModics Inc, Major Products and Services
SurModics Inc Number of Pipeline Products by Development Stage
SurModics Inc Pipeline Products Summary by Development Stage
SurModics Inc Ongoing Clinical Trials by Trial Status
SurModics Inc Ongoing Clinical Trials Summary
0.018” OTW Dual Lumen PTA Catheter - Product Status 0.018” OTW Dual Lumen PTA Catheter - Product Description 0.018” RX Dual Lumen PTA Catheter - Product Status 0.018” RX Dual Lumen PTA Catheter - Product Description 0.035” Large Diameter OTW PTA Catheter - Product Status 0.035” Large Diameter OTW PTA Catheter - Product Description 0.035” Next Generation Workhorse PTA Catheter - Product Status 0.035” Next Generation Workhorse PTA Catheter - Product Description
Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Status
Drug Coated Balloon - Arterio Venous (AV) Fistulas - Product Description
Drug Coated Balloon - Below The Knee (BTK) - Product Status
Drug Coated Balloon - Below The Knee (BTK) - Product Description
Guide Sheath - Product Status
Guide Sheath - Product Description
I-vation Sustained Drug Delivery System - TA - Product Status
I-vation Sustained Drug Delivery System - TA - Product Description
Neuraxo Implant - Product Status
Neuraxo Implant - Product Description
Renal Stent System - Product Status
Renal Stent System - Product Description
SurVeil Drug Coated Balloon - Coronary - Product Status
SurVeil Drug Coated Balloon - Coronary - Product Description
SurVeil Drug Coated Balloon - Peripheral Artery Disease - Product Status
SurVeil Drug Coated Balloon - Peripheral Artery Disease - Product Description
SurVeil Drug Coated Balloon - Peripheral Artery Disease - A Prospective, Multi-center, Single-arm Trial to Assess the Safety and Feasibility of the SurModics Drug Coated Balloon in the Treatment of Subjects with De Novo Lesions of the Femoropopliteal Artery
SurVeil Drug Coated Balloon - Peripheral Artery Disease - The Randomized and Controlled Noninferiority Trial to Evaluate Safety and Clinical Efficacy of the SurVeil Drug-coated Balloon in the Treatment of Subjects with Stenotic Lesions of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon
SurModics Inc, Key Employees
SurModics Inc, Key Employee Biographies
SurModics Inc, Other Locations
SurModics Inc, Subsidiaries
Glossary
List of Figures
SurModics Inc Pipeline Products by Equipment Type
SurModics Inc Pipeline Products by Development Stage
SurModics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report